Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New scan could help doctors better target liver cancer treatments

NCT ID NCT02881554

Summary

This study tested a special type of scan to see if it could accurately measure how well the liver is working in patients with liver cancer. The goal was to see if tracking liver function before, during, and after standard treatments like radiation or surgery could help doctors plan safer, more effective care. The study was a small pilot to gather initial information and has been terminated.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washington, 98109, United States

  • ProCure Proton Therapy Center-Seattle

    Seattle, Washington, 98133, United States

Conditions

Explore the condition pages connected to this study.